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Edited by Judit Ova´diAbstract Castanospermine was identiﬁed as an inhibitor of the
Rho/Ras-glucosylating Clostridium sordellii lethal toxin and
Clostridium diﬃcile toxin B. Microinjection of castanospermine
into embryonic bovine lung cells prevented the cytotoxic eﬀects
of toxins. The crystal structure of the glucosyltransferase do-
main of C. sordellii lethal toxin in complex with castanosper-
mine, UDP and a calcium ion was solved at a resolution of
2.3 A˚. The inhibitor binds in a conformation that brings its four
hydroxyl groups and its N-atom almost exactly in the positions
of the four hydroxyls and of the ring oxygen of the glucosyl moi-
ety of UDP–glucose, respectively.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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lethal toxin1. Introduction
Clostridial glucosylating toxins comprise a family of 250–
308 kDa exotoxins, which inactivate low molecular mass GTP-
ases of the Rho and Ras subfamilies of eukaryotic target cells
by mono-O-glucosylation [1,2]. Several important virulence
factors belong to this toxin family, including Clostridium diﬃ-
cile toxins A and B, which cause antibiotics-associated diar-
rhea and pseudomembranous colitis [3]. Other members of
this toxin family are the lethal toxin and hemorrhagic toxin
from C. sordellii and C. novyi a-toxin. Whereas C. novyi a-tox-
in uses UDP-N-acetylglucosamine as a co-substrate, all other
glucosylating toxins utilize UDP–glucose as sugar donor [4].
The toxins diﬀer slightly in their protein substrate speciﬁcity.
Whereas C. diﬃcile toxins A and B, C. sordellii hemorrhagic
toxin and C. novyi a-toxin glucosylate Rho proteins, including
RhoA, B and C, Rac and Cdc42, the lethal toxin of C. sordellii
modiﬁes Ras subfamily proteins, including Ras, Ral and Rap
also Rac but not RhoA [1,5,6]. Glucosylation of Rho/Ras pro-
teins occurs at Thr35 (e.g., in Ras/Rac) or Thr37 (e.g., in
RhoA), a modiﬁcation, which inactivates the GTPases and
inhibits downstream signaling pathways [1].*Corresponding author. Fax: +49 7612035311.
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doi:10.1016/j.febslet.2008.05.025The toxins consist of at least four domains having a receptor
bindingdomainat theC-terminus and the glucosyltransferasedo-
main at the N-terminus. The middle part appears to be responsi-
ble for processing and translocation of the toxins. Recently, the
crystal structures of the glucosyltransferase domains of toxin B,
lethal toxin and a-toxin, which are translocated into the cytosol
of target cells, were solved [7,8]. These studies showed that the
toxins belong to the GT-A family of glycosyltransferases.
Here we report that the glucosidase inhibitor castanosper-
mine inhibits the catalytic domain of the toxins. With the pre-
sentation of the 3D-structure of castanospermine in a complex
with lethal toxin of C. sordellii we provide major insights into
the inhibiting mechanism of the compound.2. Materials and methods
2.1. Materials
UDP–[14C]glucose (287.4 mCi/mmol) was obtained from Perkin–El-
mer Life Science, castanospermine from Tocris Biosciences, deoxynoji-
rimycine (DNJ) and N-butyl-deoxynojirimycine (NB-DNJ) from
Sigma. Toxin B from C. diﬃcile VPI 10463 and lethal toxin (LT) from
C. sordellii 6018 were puriﬁed as described elsewhere [9].
2.2. Expression of recombinant proteins
Toxin fragments (LT546 amino acids 1–546 of C. sordellii lethal tox-
in) and Rac1 were expressed and puriﬁed as glutathione S-transferase
fusion proteins as previously reported [10,11].
2.3. Glucosylation reaction
Rac (8.7 lM) was incubated with the indicated concentrations of re-
combinant toxin fragments and 10 lM UDP–[14C]sugars in a buﬀer,
containing 50 mM HEPES (pH 7.5), 100 mM KCl, 2 mM MgCl2
and 1 mM MnCl2 for 15 min at 30 C (20 ll total volume). Labeled
proteins were analyzed by SDS–PAGE followed by phosphorimaging
(Molecular Dynamics/GE Healthcare, Freiburg, Germany). Quantiﬁ-
cation was performed with ImageQuant (Molecular Dynamics).
2.4. UDP–sugar hydrolase reaction
UDP–sugar hydrolysis was performed as described [11]. Toxin frag-
ments were incubated with 20 lM UDP–[14C]sugar and 80 lM unla-
beled UDP–sugar in a buﬀer, containing 50 mM HEPES (pH 7.5),
100 mM KCl, 2 mM MgCl2 and 100 lM MnCl2 for 30 min at 30 C.
Samples (1 ll) were subjected to PEI (polyethyleneimine)-cellulose thin
layer chromatography (Merck, Darmstadt, Germany) (mobile phase:
0.2 mM LiCl) to separate the hydrolyzed sugar from UDP–sugar.
The plates were dried and analyzed by PhosphorImager analysis.
2.5. Microinjection studies
For microinjection, embryonic bovine lung (EBL) cells were seeded
on CELLocate coverslips (Eppendorf, Hamburg, Germany) at about
104 cells/dish and cultivated for 24 h in Dulbeccos modiﬁed Eaglesblished by Elsevier B.V. All rights reserved.
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at 37 C. Microinjection of castanospermine or buﬀer (Tris 50 mM)
was performed with the microinjector 5242 and micromanipulator
5171 from Eppendorf.Fig. 1. Inhibition of the enzyme activity of C. sordellii lethal toxin by transiti
The catalytic domain of lethal toxin (1 nM) was incubated with recombinan
deoxynojirimycine (DNJ) (1), N-butyl-deoxynojirimycine (NB-DNJ) (2) and
by SDS–PAGE and phosphorimaging. (B) Inhibition of the UDP–sugar h
incubated with radiolabeled UDP–[14C]glucose. Cleavage of UDP–gluco
phosphorimaging. IC50 values are indicated. Data are shown in means ± S.D
Fig. 2. Inhibition of the enzyme activity of C. diﬃcile toxin B by castanosper
increasing concentrations of castanospermine with UDP–[14C]glucose. Radio
(B) UDP–glucose hydrolase activity of C. diﬃcile toxin B (300 nM) was
analyzed by PEI-cellulose thin layer chromatography and phosphorimaging2.6. Structure analysis and reﬁnement
Crystals were grown using the hanging drop method at 293 K. The
crystallization condition was 100 mM Tris–HCl pH 8.5, 20% (w/v)
PEG 4000, 200 mM CaCl2. The drop contained 3.7 ll 8.8 mg/mlon state mimicking compounds. (A) Inhibition of glucosylation of Rac.
t Rac and UDP–[14C]glucose at increasing concentrations of glucose,
castanospermine (3), respectively. Radiolabeled proteins were analyzed
ydrolase reaction. The catalytic domain of lethal toxin (300 nM) was
se was analyzed by PEI-cellulose thin layer chromatography and
. (n = 3).
mine. (A) In vitro glucosylation of Rac by C. diﬃcile toxin B (5 nM) at
labeled proteins were analyzed by SDS–PAGE and autoradiography.
determined with radiolabeled UDP–glucose. Cleavage products were
. IC50 values are indicated. Data are shown in means ± S.D. (n = 6).
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The crystals reached ﬁnal sizes up to 2000 lm · 250 lm · 50 lm.
One crystal was soaked for 10 min with 2 mM UDP and 5 mM cast-
anospermine. After 1 min soaking in reservoir buﬀer containing 30%
(v/v) ethyleneglycol, the crystal was ﬂash-frozen in liquid nitrogen
for X-ray data collection. The data were collected at the SLS (beamline
X06SA, Villigen, Switzerland). Data processing were done with XDS
[12] (Supplementary Table). Castanospermine was modeled into the
electron density. The model was reﬁned with REFMAC5 [13]. Water
molecules were added automatically with ARP/wARP [14]. Manual
building was done using COOT [15]. The ligand was created with
PRODRG [16]. Structure validation was done with PROCHECK
[13]. Figures were prepared using POVScript+ [17] and POVRAY
(http://www.povray.org).3. Results
We tested several azasugar derivatives, which are known to
be potent glycosidase inhibitors, for their potency to inhibit the
glucosyltransferase activity of C. sordellii lethal toxin. As
shown in Fig. 1A, deoxynojirimycine (DNJ) inhibited glucosy-
lation of Rac with an IC50 value of about 2 mM. A similar IC50
value of 1 mM was obtained for the N-alkylated form of DNJ
(N-butyl-deoxynojirimycine, NB-DNJ). Almost at the same
concentrations the compounds inhibited the glycohydrolase
activity of the toxins (Fig. 1B) indicating that the azasugars
act by inhibiting the catalytic activity and not the interaction
between the enzyme and its protein substrate. The plant alka-
loid castanospermine is another polyhydroxypyridine analog,Fig. 3. Protection of cell intoxication by microinjection of castanospermine in
was injected into embryonic bovine lung (EBL) cells (marked with an arr
C. sordellii lethal toxin (A, C) or 100 ng/ml C. diﬃcile toxin B (B) were appliwhich is related to azasugars. This compound has been shown
in various studies to inhibit glycosidases [18,19]. As compared
to deoxynojirimycine and N-butyl-deoxynojirimycine, castano-
spermine was more potent to inhibit glucosylation of Rac or
glycohydrolysis of UDP–glucose by the catalytic domain of
lethal toxin (IC50  100 lM). Also full length lethal toxin
was inhibited by castanospermine with similar potency (IC50
for inhibition of glucosylation 180 lM).
In addition, we tested the inhibiting potential of castanosper-
mine on the glucosyltransferase and -hydrolase activity of C.
diﬃcile toxin B. The compound also blocked the enzyme activ-
ity of this toxin (Fig. 2A and B). Several other sugar related
analogs (conduritol-B-epoxide (CBE), DMDP ((2R,5R)-bis-
(hydroxymethyl)-(3R,4R)-dihydroxypyrrolidine), bromocon-
duritol (6-bromo-3,4,5-trihydroxycyclohex-1-ene)) were tested
without signiﬁcant inhibition of the toxins activity (data not
shown).
To test the inhibiting eﬀect of castanospermine on clostridial
glucosylating toxins in intact cells, we studied the inﬂuence of
castanospermine on toxin-induced cell morphological changes.
Lethal toxin and toxin B caused the typical cytotoxic eﬀects on
embryonic bovine lung cells, which are characterized by
shrinking and rounding-up of the cell body and formation of
neurite-like processes. These morphological changes were com-
pletely blocked by previous microinjection of castanospermine
into the target cells (Fig. 3A and B).
To get further insights into the mechanism of inhibition, we
crystallized the enzyme domain of lethal toxin and produced ato EBL-cells. Castanospermine (1 mM, A and B) or control buﬀer (C)
ow). Cells were regenerated for 1 h at 37 C. Afterwards 250 ng/ml
ed to the medium. Photographs were taken 3 h after toxin application.
Fig. 4. Binding structure of castanospermine to the catalytic fragment of lethal toxin from C. sordellii. (A) Stereoview of the ribbon plot of lethal
toxin (blue) with bound UDP and castanospermine (yellow ball-and-stick models) and Ca2+ (pink). (B) Stereoview of the binding structures of Ca2+,
UDP and the inhibitor in the (Fo  Fc)-electron density of a simulated annealing omit map at a 3.0r contour level. Chain cuts are marked by halos.
Hydrogen bonds are dotted lines. Some water molecules are shown in red. (C) Stereoview of the binding structure of Ca2+, UDP and
castanospermine in lethal toxin (cyan) superimposed with the binding structures of Mn2+ and UDP–glucose in lethal toxin (grey) [8] as well as Mn2+,
UDP and glucose in toxin B of C. diﬃcile (orange) [7]. The N-atom of the inhibitor is at distances of 0.4 A˚ and 1.2 A˚ to the O500 and C100 atoms of
UDP–glucose, respectively.
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Fig. 5. Enhancement of the inhibiting eﬀect of castanospermine in the presence of UDP. (A) Inhibition of glucosyltransferase activity of the catalytic
domain of lethal toxin (1 nM) was studied at increasing concentrations of castanospermine (), UDP () and an equimolar mixture of
castanospermine and UDP (.) with Rac and UDP–[14C]glucose. Radiolabeled proteins were analyzed by SDS–PAGE and phosphorimaging. (B)
Inhibition of UDP–glucose hydrolysis. UDP–glucose hydrolysis by the catalytic domain of lethal toxin (300 nM) was determined at increasing
concentrations of castanospermine (), UDP () and an equimolar mixture of castanospermine and UDP (.). Cleaved radiolabeled products from
UDP–[14C]glucose were separated by PEI-cellulose thin layer chromatography, analyzed by autoradiography and quantiﬁed with ImageQuant. Data
are shown in means ± S.D. (n = 3).
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to crystallize the complex in the presence of manganese salts
failed, we obtained suitable crystals in the presence of calcium
and UDP (Supplementary Table). The structure of the com-
plex between lethal toxin and Ca2+, UDP as well as castano-
spermine was solved by the molecular replacement method at
2.3 A˚ resolution (Fig. 4A). The polypeptide conformation
was closely similar to that of a complex between lethal toxin
and Ca2+ together with UDP–glucose [8]. The rmsd of the
Ca atoms was 0.3 A˚. The Ca2+ coordination diﬀers with re-
spect to the identiﬁed water molecules [8]. The castanosper-
mine conformation is well-established by the diﬀerence
electron density (Fig. 4B). In Fig. 4C, the binding mode of
the inhibitor is superimposed on UDP–glucose as bound in a
catalytically competent Mn2+ complex of lethal toxin [8] and
in a complex between the toxin B of C. diﬃcile [7] and
Mn2+, UDP as well as glucose. This superposition demon-
strates that the four hydroxyls of the inhibitor are almost ex-
actly in the positions of the respective hydroxyls of UDP–
glucose and of glucose. The non-polar ethylene bridge between
the 6-hydroxyl group and the N-atom of castanospermine is in
a non-polar pocket formed by Ile383, Thr465, Ile466 and
Pro471, which is an appropriate place. The N-atom is very
close to the pyranose ring oxygen of UDP–glucose and forms
a salt-bridge to the b-phosphoryl group of UDP suggesting
that the presence of UDP increases the binding strength.
Therefore, we tested whether UDP had any eﬀect on inhibi-
tion of lethal toxin-catalyzed glucosylation of Rac by castano-
spermine. UDP alone had only a weak inhibiting activity. By
application of both UDP and castanospermine, the inhibition
curve was shifted to the left and the IC50 value (30 lM for
inhibition of glucosylation) was reduced by about 3-fold
(Fig. 5A). A similar result was observed for inhibition of the
glycohydrolase activity by castanospermine (Fig. 5B). Again
in the presence of UDP, castanospermine was about 3-fold
more potent to inhibit glycohydrolase activity than in its ab-
sence.4. Discussion
Inhibitors of clostridial glucosylating toxins are of potential
therapeutic value. UDP–mannose has been described as an
inhibitor of the action of C. sordellii lethal toxin [20]. Its inhib-
iting potency is in the mM range and its mechanism is not well
deﬁned. Here we studied the eﬀects of castanospermine, which
is a polyhydroxylated indolizidine alkaloid from the seeds of
the black bean tree Castanospermum australe, on the glucosyl-
transferase activities of C. sordellii lethal toxin and C. diﬃcile
toxin B and obtained IC50 values of 100–400 lM for the inhibi-
tion of glucosylation of Rac. Castanospermine was more potent
than the related compounds deoxynojirimycine and N-butyl-
deoxynojirimycine. At the same concentrations, castanosper-
mine inhibited the glucosylhydrolase activity of the toxins, indi-
cating that the enzyme–protein substrate interaction was not
blocked. Castanospermine and the related compounds are well
known inhibitors of glycosidases [18,19,21]. They inhibit glyco-
sidases of diﬀerent types with largely diﬀerent potencies.
It has been suggested that castanospermine and related com-
pounds act as transition state mimicking structures to inhibit
glycosidase reaction [18]. Structural basis is most likely its po-
sitive charge and the geometric restriction of the bicycle. The
mechanism involved in hydrolysis of the glycosidic bond is well
understood for most retaining and inverting glycosidases. In
many cases, it is suggested that the transition state involves
an oxocarbenium cation-like transition state [22] with distor-
tion of the substrate sugar into a boat or half-chair conforma-
tion to lower the energy barrier of the transfer reaction.
Accordingly, it has been reported for the b-glucosidase
TmGH1 from Thermotoga maritime that castanospermine is
bound in a boat conformation [18], actually diﬀerent from
the structure seen in the small molecule crystal structure of
castanospermine [23]. The binding structure of castanosper-
mine in lethal toxin (Fig. 4) corresponds closely to that of
UDP–glucose in a catalytically competent complex [8]. In or-
der to ﬁt the four hydroxyl positions of UDP–glucose, the
2282 T. Jank et al. / FEBS Letters 582 (2008) 2277–2282inhibitor assumes an unusual conformation. Its positively
charged N-atom is located almost exactly at the position where
the putative transient positive charge of the carboxonium ion
is expected. The observed binding structure suggests that the
6-epimer of castanospermine binds more eﬀectively than the
inhibitor itself. Moreover, it suggests that additions at atoms
C1 and C8 may diﬀerentiate between diﬀerent protein sub-
strates. Even more importantly, such additions may avoid
side-reactions with other glycosyltransferases.
The observation that UDP increased the potency of castano-
spermine is well-explained by the structure, because the b-
phosphate of UDP forms an energetically favorable salt-bridge
with the nitrogen of castanospermine (Fig. 4C). Since the
nitrogen atom of castanospermine is located within 1 A˚ at
the C100 and O500 positions of the substrate UDP–glucose
(Fig. 4C), the observed castanospermine binding structure sug-
gests that such a salt-bridge may be an intermediate of the gly-
cosyltransfer reaction, as recently proposed in the circular
electron transfer mechanism [8]. Consequently, Fig. 4C sup-
ports the circular mechanism that suggests the formation of
such a salt-bridge as the initial step, which is then followed
by the nucleophilic attack of the sugar-accepting atom [8]. Ta-
ken together, our studies show that the glucosidase inhibitor
and transition state mimic castanospermine potently inhibits
Rho/Ras-GTPases glucosylating toxins. Moreover, castano-
spermine is a potential lead structure for the development of
therapeutic inhibitors of clostridial glucosylating toxins.
Protein accession code: The data were deposited in the Pro-
tein Data Bank under accession code 2VL8.
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